Manuscript: 2018 recommendations for the management of community acquired pneumonia
Publication: J Bras Pneumol. 44(5):405-423
DOI: 10.1590/S1806-37562018000000130
On page 416, where is written:
“Chart 6. Dosing, dosing schedule, and routes of administration of antibiotics that can be used in the treatment of community-acquired pneumonia.”
Chart 6. Dosing, dosing schedule, and routes of administration of antibiotics that can be used in the treatment of community-acquired pneumonia.
| Drug | Route | Dose | Interval, h |
|---|---|---|---|
| Amoxicillin | Oral | 500 mg | 8 |
| Amoxicillin/clavulanic acid | Oral | 875/125 mg | 12 |
| Amoxicillin/clavulanic acid | Oral | 500/125 mg | 8 |
| Amoxicillin/clavulanic acid | Intravenous | 1,000/200 mg | 8* |
| Ampicillin/sulbactam | Intravenous | 1.5/3.0 g | 6-8 |
| Azithromycin | Oral-intravenous | 500 mg | 24 |
| Cefepime | Intravenous | 2g | 12 |
| Cefotaxime | Intravenous | 1-2 g | 8 |
| Ceftaroline | Intravenous | 600 mg | 12 |
| Ceftriaxone | Intravenous | 1 g | 12 |
| Ciprofloxacin | Oral | 500-750 mg | 12 |
| Ciprofloxacin | Intravenous | 400 mg | 8-12 |
| Clarithromycin | Oral | 500 mg | 12 |
| Extended-release clarithromycin | Oral | 1,000 mg | 24 |
| Clarithromycin | Intravenous | 500 mg | 12 |
| Clindamycin | Oral | 600 mg | 8-12 |
| Clindamycin | Intravenous | 600 mg | 8 |
| Ertapenem | Intravenous | 1 g | 24 |
| Imipenem | Intravenous | 1 g | 8 |
| Levofloxacin | Oral | 500-750 mg | 24 |
| Levofloxacin | Intravenous | 500-750 mg | 24 |
| Linezolid | Oral-intravenous | 600 mg | 12 |
| Meropenem | Intravenous | 1 g | 8 |
| Moxifloxacin | Oral-intravenous | 400 mg | 24 |
| Piperacillin/tazobactam | Intravenous | 4.0/0.5 g | 6-8 |
| Vancomycin | Intravenous | 500/1,000 mg | 6/12 |
*
Dosing schedule can be modified to every 6 hours in cases of severe infection.
It should be read (changes in bold type):